Plasma microRNA‐16‐5p, ‐17‐5p and ‐20a‐5p: Novel diagnostic biomarkers for gestational diabetes mellitus
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Aim: To explore whether plasma microRNA‐16‐5p, ‐17‐5p and ‐20a‐5p can be used as diagnostic biomarkers in gestational diabetes mellitus (GDM) and to investigate the relationship between those microRNAs and the risk factors of GDM (body mass index [BMI], insulin resistance [IR] and tumor necrosis factor‐α (TNF‐α)). Methods: A total of 85 pregnant women with GDM and 72 pregnant women without GDM were enrolled in this study. The plasma concentration of microRNAs (microRNA‐16‐5p, ‐17‐5p, ‐19a‐3p, ‐19b‐3p, ‐20a‐5p) was measured using quantitative reverse transcription–polymerase chain reaction (qRT‐PCR). Spearman's correlation analysis was used to evaluate the correlation between those microRNAs and the risk factors of GDM, and receiver operating characteristic curve analysis was used to evaluate diagnostic sensitivity and specificity. Results: Compared with non‐GDM women, the relative and absolute expression of plasma microRNA‐16‐5p, ‐17‐5p, ‐20a‐5p from GDM women were significantly upregulated, when those women were diagnosed as GDM. During pregnancy, the expression of those microRNAs from GDM women also were significantly upregulated. The expression of those microRNAs was also positively correlated with IR, a risk factor of GDM. Plasma microRNA‐16‐5p, ‐17‐5p, ‐20a‐5p reflected an obvious separation between GDM women and non‐GDM women, with areas under the curve of 0.92 (95%CI: 0.871–0.984), 0.88 (95%CI: 0.798–0.962), and 0.74 (95%CI: 0.618–0.870), respectively, cut‐offs >2554, 1820, 3886 copies/μL, respectively; sensitivity 41.6%, 21.4% and 17.8%, respectively; and specificity 95.8%, 95.4% and 95.4%, respectively. Conclusion: Plasma microRNA‐16‐5p, ‐17‐5p and ‐20a‐5p are potential diagnostic biomarkers in GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303
Early Second-Trimester Serum MiRNA Profiling Predicts Gestational Diabetes Mellitus
Zhao, C., Dong, J., Jiang, T., Shi, Z., Yu, B., Zhu, Y., Chen, D., Xu, J., Huo, R., Dai, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023925 · Cited by 230 · cited 1×
“In addition, microRNA-508-3p was upregulated and microRNA27a, -9, -137, -92a, -33a, -30d, -362-5p and -502-5p were downregulated in placental tissues of GDM,(14) while the expression of microRNA-132, -29a and -222 was significantly downregulated in serum samples of GDM women.(15)”
BackgroundHyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia
(2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.01.024 · Cited by 155
Gestational diabetes mellitus: An update on the current international diagnostic criteria
Agarwal, M. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.782 · Cited by 128 · cited 1×
“American Diabetes Association (ADA) and Diabetes and Pregnancy Study Groups (IADPSG) criteria.(22) Figure 1 Relative expression of the microRNA (a) -16-5p, (b) -17-5p, (c) -19a-3p, (d) -19b-3p and (e) -20a-5p at the time of diagnosis of gestational diabetes mellitus (GDM).”
BackgroundA MicroRNA Signature in Gestational Diabetes Mellitus Associated with Risk of Macrosomia
Li, J., Song, L., Zhou, L., Wu, J., Sheng, C., Chen, H., Liu, Y., Gao, S., & Huang, W. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430349 · Cited by 123
Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria
Djelmis, J., Pavić, M., Mulliqi Kotori, V., Pavlić Renar, I., Ivanisevic, M., & Oreskovic, S. (2016) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2016.07.005 · Cited by 53
Cited by
Lorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., & Lorenzo, Ó. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0935-9 · Cited by 202
Molecular Biomarkers for Gestational Diabetes Mellitus and Postpartum Diabetes
Lu, W., & Hu, C. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002160 · Cited by 52
Biochemical and Molecular Biomarkers: Unraveling Their Role in Gestational Diabetes Mellitus
Karami, M., Mousavi, S. H., Rafiee, M., Heidari, R., & Shahrokhi, S. Z. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00980-8 · Cited by 33
Exploring the potential of microRNA as a diagnostic tool for gestational diabetes
Elhag, D. A., & Al Khodor, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04269-2 · Cited by 20
“The observed upregulation of miRNAs was also shown to be positively correlated with insulin resistance (IR), a known risk factor for GDM [31].”
BackgroundResultInfluential
Metadata
- Authors
- Cao, Y., Jia, Y., Xing, B., Shi, D., & Dong, X.
- Venue
- Journal of Obstetrics and Gynaecology Research
- Publisher
- Wiley
- Published
- 2017-06
- Volume
- 43
- Issue
- 6
- Pages
- 974-981
- ISSN
- 1341-8076 (ISSN-L)
- 1447-0756
- OpenAlex
- W2625391457
- Cited by
- 110
- References
- 8
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.